Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J.
Clin Infect Dis. 2012 Mar 1;54(5):621-9. Epub 2012 Jan 12.
Related citations
Antibiotic treatment against methicillin-resistant Staphylococcus aureus hospital- and ventilator-acquired pneumonia: a step forward but the battle continues.
Torres A.
Clin Infect Dis. 2012 Mar 1;54(5):630-2. Epub 2012 Jan 12. No abstract available.
An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection.
Miller CE, Batra R, Cooper BS, Patel AK, Klein J, Otter JA, Kypraios T, French GL, Tosas O, Edgeworth JD.
Clin Infect Dis. 2012 Mar 1;54(5):591-600. Epub 2011 Dec 20.
Wounds, functional disability, and indwelling devices are associated with cocolonization by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in southeast Michigan.
Flannery EL, Wang L, Zöllner S, Foxman B, Mobley HL, Mody L.
Clin Infect Dis. 2011 Dec;53(12):1215-22.
Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ.
Clin Infect Dis. 2012 Jan 1;54(1):51-8. Epub 2011 Nov 21.
Daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infection and elevated vancomycin minimum inhibitory concentrations: has the time come?
Weston A, Boucher HW.
Clin Infect Dis. 2012 Jan 1;54(1):59-61. Epub 2011 Nov 21. No abstract available.
High prevalence of methicillin-resistant Staphylococcus aureus among residents and staff of long-term care facilities, involving joint and parallel evolution.
Schwaber MJ, Masarwa S, Navon-Venezia S, Kandlik Y, Chmelnitsky I, Smollan G, Glick R, Neria G, Carmeli Y.
Clin Infect Dis. 2011 Nov;53(9):910-3.
Best alternative to vancomycin for serious methicillin-resistant Staphylococcus aureus infections: let's just say it.
Bush LM.
Clin Infect Dis. 2011 Nov;53(9):965-6. Epub 2011 Aug 31. No abstract available.
Methicillin-resistant Staphylococcus aureus (MRSA) isolated from pets living in households with MRSA-infected children.
Bender JB, Waters KC, Nerby J, Olsen KE, Jawahir S.
Clin Infect Dis. 2012 Feb 1;54(3):449-50. Epub 2011 Oct 31. No abstract available.
Doubtful model utility in predicting high vancomycin minimum inhibitory concentration methicillin-resistant Staphylococcus aureus bloodstream infection episodes.
van Hal SJ, Jones M, Paterson DL, Gosbell IB.
Clin Infect Dis. 2011 Dec;53(11):1166-7; author's reply 1167-8. Epub 2011 Oct 21. No abstract available.
Outpatient antibiotic use in the United States: time to "get smarter".
Huttner B, Samore M.
Clin Infect Dis. 2011 Oct;53(7):640-3. No abstract available.
Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.
Hicks LA, Chien YW, Taylor TH Jr, Haber M, Klugman KP; Active Bacterial Core Surveillance (ABCs) Team.
Clin Infect Dis. 2011 Oct;53(7):631-9.
The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes.
Cameron DR, Howden BP, Peleg AY.
Clin Infect Dis. 2011 Sep;53(6):576-82. Review.
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.
Kollef MH, Golan Y, Micek ST, Shorr AF, Restrepo MI.
Clin Infect Dis. 2011 Sep;53 Suppl 2:S33-55; quiz S56-8. Review.
Predictors of clinical virulence in community-onset methicillin-resistant Staphylococcus aureus infections: the importance of USA300 and pneumonia.
Hota B, Lyles R, Rim J, Popovich KJ, Rice T, Aroutcheva A, Weinstein RA; CDC Prevention Epicenters.
Clin Infect Dis. 2011 Oct;53(8):757-65. Epub 2011 Aug 31.
Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine Leukocidin gene.
Peyrani P, Allen M, Wiemken TL, Haque NZ, Zervos MJ, Ford KD, Scerpella EG, Mangino JE, Kett DH, Ramirez JA; IMPACT-HAP Study Group.
Clin Infect Dis. 2011 Oct;53(8):766-71. Epub 2011 Aug 31.
Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission.
Milstone AM, Goldner BW, Ross T, Shepard JW, Carroll KC, Perl TM.
Clin Infect Dis. 2011 Nov;53(9):853-9. Epub 2011 Aug 29.
Apropos: the challenge of antimicrobial resistance in Brazil.
Arya SC, Agarwal N.
Clin Infect Dis. 2011 Aug;53(4):401-2. No abstract available.
Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa.
Jacobson KR, Theron D, Victor TC, Streicher EM, Warren RM, Murray MB.
Clin Infect Dis. 2011 Aug;53(4):369-72.
Need and potential of antimicrobial stewardship in community hospitals.
Septimus EJ, Owens RC Jr.
Clin Infect Dis. 2011 Aug;53 Suppl 1:S8-S14. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on